SCHEMBL21496940

SCHEMBL21496940

CC1(C(=O)ONC(=O)c2cccc3cc[nH]c23)CC2(CCC2)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDPK1 O15530 1/20 0.44
▸ HDAC1 Q13547 4/20 0.43
▸ HDAC2 Q92769 3/20 0.43
▸ HDAC3 O15379 3/20 0.43
▸ HDAC4 P56524 2/20 0.43
▸ HDAC7 Q8WUI4 2/20 0.43
▸ HDAC10 Q969S8 2/20 0.43
▸ HDAC11 Q96DB2 2/20 0.43
▸ HDAC8 Q9BY41 2/20 0.43
▸ HDAC6 Q9UBN7 2/20 0.43
▸ HDAC9 Q9UKV0 2/20 0.43
▸ HDAC5 Q9UQL6 2/20 0.43
▸ KEAP1 Q14145 1/20 0.42
▸ GRM5 P41594 1/20 0.41
▸ MAPT P10636 5/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ NPSR1 Q6W5P4 2/20 0.39
▸ KMT2A Q03164 3/20 0.38
▸ MEN1 O00255 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23984749 0.70 KEAP1 (0.58) PDPK1HDAC1HDAC2HDAC3HDAC4
SCHEMBL31358814 0.70 KEAP1 (0.66) PDPK1HDAC1HDAC2HDAC3HDAC4
SCHEMBL21496939 0.69 KEAP1 (0.44) PDPK1HDAC1HDAC2HDAC3HDAC4
SCHEMBL6219389 0.68 KEAP1 (0.64) PDPK1HDAC1HDAC2HDAC3HDAC4
SCHEMBL9973783 0.68 PDPK1 (0.67) PDPK1HDAC1HDAC2HDAC3HDAC4
SCHEMBL31203422 0.67 KEAP1 (0.47) PDPK1HDAC1HDAC2HDAC3HDAC4
SCHEMBL30136593 0.66 KEAP1 (0.64) PDPK1HDAC1HDAC2HDAC3HDAC4
SCHEMBL761721 0.66 KEAP1 (0.64) PDPK1HDAC1HDAC2HDAC3HDAC4
SCHEMBL23985232 0.65 HDAC1 (0.59) PDPK1HDAC1HDAC2HDAC3HDAC4
SCHEMBL24897838 0.65 KEAP1 (0.58) PDPK1HDAC1HDAC2HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3781550-A1 BICYCLIC CARBOXAMIDES AND METHODS OF USE THEREOF Tempest Therapeutics, Inc. (US) 2021-02-24 — — EP disclosed
WO-2019204523-A1 BICYCLIC CARBOXAMIDES AND METHODS OF USE THEREOF TEMPEST THERAPEUTICS, INC. (US) 2019-10-24 — — WO disclosed
Send feedback